TherapeuticsMD, Inc.

TherapeuticsMD, Inc. (TXMD) is a publicly traded US company. TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

The company reports trailing twelve-month revenue of $724,000 and net income of $95,000.

Key metrics include a return on equity of 0.4%, a debt-to-equity ratio of 0.39.

Investors tracking TXMD can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.